Praxis Precision Medicines, Inc. Announces Proposed Public O

27.03.2024 - BOSTON, March 27, 2024 (GLOBE NEWSWIRE) - Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders ...

Related Keywords

New York , United States , , Equity Syndicate Department , Piper Sandler Co , Truist Securities Inc , Exchange Commission , Prospectus Department , Guggenheim Securities , Piper Sandler , Truist Securities , Private Securities Litigation Reform Act , Praxi Annual Report , Investor Contact , Praxis Precision Medicines , Dan Ferry Life Science Advisors ,